Skip to main content

Membranes for Dialysis and Hemofiltration

  • Chapter
  • First Online:
Management of Acute Kidney Problems

Abstract

Materials for dialyzers and hemofilters are either based on cellulose or modified cellulosic membranes or made from synthetic polymers such as polysulfone, polyethersulfone, polyamide, polyacrylonitrile, or polymethylmethacrylate. Membranes can be classified according to permeability (water flux and permeability for larger molecules) and biocompatibility characteristics. The latter may include properties such as: Complement system activation Cell activation Reactive oxygen species production Cell aggregate formation Premature cellular senescence Coagulation system activation Increased apoptosis Contact phase system activation Requirements for modern dialysis membrane include: High diffusive clearance High permeability for uremic middle molecules Adequate hydraulic permeability Pyrogen retention capability High biocompatibility

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Albright RC Jr, Smelser JM, McCarthy JT, Homburger HA, Bergstralh EJ, Larson TS (2000) Patient survival and renal recovery in acute renal failure: randomized comparison of cellulose acetate and polysulfone membrane dialyzers. Mayo Clin Proc 75:1141–1147.

    Article  PubMed  Google Scholar 

  2. Alonso A, Lau J, Jaber BL (2008) Biocompatible hemodialysis membranes for acute renal failure. Cochrane Database Syst Rev 23:CD005283

    Google Scholar 

  3. Aoike I (2007) Clinical significance of protein adsorbable membranes – Long-term clinical effects and analysis using a proteomic technique. Nephrol Dial Transplant 22(Suppl. 5):v13–v19.

    Article  CAS  PubMed  Google Scholar 

  4. Babb AL, Popovich RP, Christopher TG, Scribner BH (1971) The genesis of the square meter-hour hypothesis. Trans Am Soc Artif Intern Organs 17:81–91.

    CAS  PubMed  Google Scholar 

  5. Canaud B, Bragg-Gresham JL, Marshall M, Desmeules S, Gillespie BW, Depner T, Klassen P, Port FK (2006) Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int 69:2087–2093.

    Article  CAS  Google Scholar 

  6. Chanard J, Lavaud S, Maheut H, Kazes I, Vitry F, Rieu P (2007) The clinical evaluation of low-dose heparin in haemodialysis: A prospective study using the heparin-coated AN69 ST membrane. Nephrol Dial Transplant Dec 21 [Epub ahead of print]

    Google Scholar 

  7. Chauveau P, Nguyen H, Combe C, et al. for the French Study Group for Nutrition in Dialysis (2005) Dialyzer membrane permeability and survival in hemodialysis patients. Am J Kidney Dis 45:565–571.

    Article  PubMed  Google Scholar 

  8. Cheung AK, Levin NW, Greene T, Agodoa L, Bailey J, Beck G, Clark W, Levey AS, Leypoldt JK, Ornt DB, Rocco MV, Schulman G, Schwab S, Teehan B, Eknoyan G (2003) Effects of high-flux hemodialysis on clinical outcomes: Results of the HEMO Study. J Am Soc Nephrol 14:3251–3263.

    Article  PubMed  Google Scholar 

  9. Craddock PR, Fehr J, Brigham KL, Kronenberg RS, Jacob HS (1977) Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med 296:769–774.

    Article  CAS  PubMed  Google Scholar 

  10. Désormeaux A, Moreau ME, Lepage Y, Chanard J, Adam A (2008) The effect of electronegativity and angiotensin-converting enzyme inhibition on the kinin-forming capacity of polyacrylonitrile dialysis membranes. Biomaterials 29:1139–1146.

    Article  PubMed  Google Scholar 

  11. De Vriese AS, Colardyn FA, Philippé JJ, Vanholder RC, De Sutter JH, Lameire NH (1999) Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 10:846–853.

    CAS  PubMed  Google Scholar 

  12. Eknoyan G, Beck GJ, Cheung AK, et al. (2002) Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347:2010–2019.

    Article  PubMed  Google Scholar 

  13. Evenepoel P, Dejagere T, Verhamme P, Claes K, Kuypers D, Bammens B, Vanrenterghem Y (2007) Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding. Am J Kidney Dis 49:642–649.

    Article  CAS  PubMed  Google Scholar 

  14. Fissell WH, Lou L, Abrishami S, Buffington DA, Humes HD (2003) Bioartificial kidney ameliorates gram-negative bacteria-induced septic shock in uremic animals. J Am Soc Nephrol 14:454–461.

    Article  PubMed  Google Scholar 

  15. Frank RD, Weber J, Dresbach H, Thelen H, Weiss C, Floege J (2001) Role of contact system activation in hemodialyzer-induced thrombogenicity. Kidney Int 60:1972–1981.

    Article  CAS  PubMed  Google Scholar 

  16. Gastaldello K, Melot C, Kahn RJ, Vanherweghem JL, Vincent JL, Tielemans C (2000) Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study. Nephrol Dial Transplant 15:224–230.

    Article  CAS  PubMed  Google Scholar 

  17. Haase M, Silvester W, Uchino S, Goldsmith D, Davenport P, Tipping P, Boyce N, Bellomo R (2007) A pilot study of high-adsorption hemofiltration in human septic shock. Int J Artif Organs 30:108–117.

    CAS  PubMed  Google Scholar 

  18. Haeffner CN, Cavaillon JM, Laude M, Kazatchkine MD (1987) C3a (C3adesArg) induces production and release of interleukin 1 by cultured human monocytes. J Immunol 139:794–799.

    Google Scholar 

  19. Hakim RM, Wingard RL, Parker RA (1994) Effect of the dialysis membrane in the treatment of patients with acute renal failure. New Engl J Med 331:1338–1342.

    Article  CAS  PubMed  Google Scholar 

  20. Hakim RM, Held PJ, Stannard DC, Wolfe RA, Port FK, Daugirdas JT, Agodoa L (1996) Effect of the dialysis membrane on mortality of chronic hemodialysis patients. Kidney Int 50:566–570.

    Article  CAS  PubMed  Google Scholar 

  21. Himmelfarb J, Ault KA, Holbrook D, Leeber DA, Hakim RM (1993) Intradialytic granulocyte reactive oxygen species production: a prospective, crossover trial. J Am Soc Nephrol 4:178–186.

    CAS  PubMed  Google Scholar 

  22. Hörl WH (2002) Hemodialysis membranes: Interleukins, biocompatibility, and middle molecules. J Am Soc Nephrol 13:S62–S71.

    PubMed  Google Scholar 

  23. Humes HD, Buffington DA, MacKay SM, Funke AJ, Weitzel WF (1999) Replacement of renal function in uremic animals with a tissue-engineered kidney. Nat Biotechnol 17:451–455.

    Article  CAS  PubMed  Google Scholar 

  24. Humes HD, Buffington DA, Lou L, Abrishami S, Wang M, Xia J, Fissell WH (2003) Cell therapy with a tissue-engineered kidney reduces the multiple-organ consequences of septic shock. Crit Care Med 31:2421–2428.

    Article  CAS  PubMed  Google Scholar 

  25. Humes HD, Weitzel WF, Bartlett RH, Swaniker FC, Paganini EP, Luderer JR, Sobota J (2004) Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int 66:1578–1588.

    Article  CAS  PubMed  Google Scholar 

  26. Humes HD, Fissell WH, Tiranathanagul K (2006) The future of hemodialysis membranes. Kidney Intl 69:1115–1119.

    Article  CAS  Google Scholar 

  27. Hutter JC, Kuehnert MJ, Wallis RR, Lucas AD, Sen S, Jarvis WR (2000) Acute onset of decreased vision and hearing traced to hemodialysis treatment with aged dialyzers. JAMA. 283:2128–2134.

    Article  CAS  PubMed  Google Scholar 

  28. Jaber BL, Lau J, Schmid CH, Karsou SA, Levey AS, Pereira BJ (2002) Effect of biocompatibility of hemodialysis membranes on mortality in acute renal failure: A meta-analysis. Clin Nephrol 57:274–282.

    CAS  PubMed  Google Scholar 

  29. Jimenez R, Carracedo J, Santamaría R, Soriano S, Madueño JA, Ramírez R, Rodríguez M, Martín-Malo A, Aljama P (2005) Replicative senescence in patients with chronic kidney failure. Kidney Int Suppl 99:S11–S15.

    Article  CAS  PubMed  Google Scholar 

  30. Jones CH, Goutcher E, Newstead CG, Will EJ, Dean SG, Davison AM (1998) Hemodynamics and survival of patients with acute renal failure treated by continuous dialysis with two synthetic membranes. Artif Organs 22:638–643.

    Article  CAS  PubMed  Google Scholar 

  31. Jörres A, Gahl GM, Dobis C, Polenakovic MH, Cakalaroski K, Rutkowski B, Kisielnicka E, Krieter DH, Rumpf KW, Guenther C, Gaus W, Hoegel J (1999) Haemodialysis-membrane biocompatibility and mortality of patients with dialysis-dependent acute renal failure: a prospective randomised multicentre trial. International Multicentre Study Group. Lancet 354:1337–1341.

    Article  PubMed  Google Scholar 

  32. Kawabata K, Nagake Y, Shikata K, Makino H, Ota Z (1996) The changes of Mac-1 and L-selectin expression on granulocytes and soluble L-selectin level during hemodialysis. Nephron 73:573–579.

    Article  CAS  PubMed  Google Scholar 

  33. Klinke B, Röckel A, Abdelhamid S, Fiegel P, Walb D (1989) Transmembranous transport and adsorption of beta-2-microglobulin during hemodialysis using polysulfone, polyacrylonitrile, polymethylmethacrylate and cuprammonium rayon membranes. Int J Artif Organs 12:697–702.

    CAS  PubMed  Google Scholar 

  34. Koda Y, Nishi S, Miyazaki S, Haginoshita S, Sakurabayashi T, Suzuki M, Sakai S, Yuasa Y, Hirasawa Y, Nishi T (1997) Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int 52:1096–1101.

    Article  CAS  PubMed  Google Scholar 

  35. Kolff WJ (1965) First clinical experience with the artificial kidney. Ann Intern Med 62:608–619.

    CAS  PubMed  Google Scholar 

  36. Krane V, Krieter DH, Olschewski M, März W, Mann JFE, Ritz E, Wanner C, for the German Diabetes and Dialysis Study Investigators (2007) Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis. Am J Kidney Dis 49:267–275.

    Article  CAS  PubMed  Google Scholar 

  37. Krieter DH, Grude M, Lemke HD, Fink E, Bönner G, Schölkens BA, Schulz E, Müller GA (1998) Anaphylactoid reactions during hemodialysis in sheep are ACE inhibitor dose-dependent and mediated by bradykinin. Kidney Int 53:1026–1035.

    Article  CAS  PubMed  Google Scholar 

  38. Krieter DH, Morgenroth A, Barasinski A, Lemke HD, Schuster O, von Harten B, Wanner C (2007) Effects of a polyelectrolyte additive on the selective dialysis membrane permeability for low-molecular-weight proteins.Nephrol Dial Transplant 22:491–499.

    Article  CAS  PubMed  Google Scholar 

  39. Krieter DH, Hunn E, Morgenroth A, Lemke HD, Wanner C (2008) Matching efficacy of online hemodiafiltration in simple hemodialysis mode. Artif Organs 32:903–909

    Google Scholar 

  40. Kurtal H, von Herrath D, Schaefer K (1995) Is the choice of membrane important for patients with acute renal failure requiring hemodialysis? Artif Organs 19:391–394.

    Article  CAS  PubMed  Google Scholar 

  41. Locatelli F, Marcelli D, Conte F, Limido A, Malberti F, Spotti D (1999) Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. The Registro Lombardo Dialisi E Trapianto. Kidney Int 55:286–293.

    Article  CAS  PubMed  Google Scholar 

  42. Locatelli F, Martin-Malo A, Hannedouche T, Loureiro A, Papadimitriou M, Wizemann V, Jacobson SH, Czekalski S, Ronco C, Vanholder R; Membrane Permeability Outcome (MPO) Study Group (2009) Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol 20:645–654

    Article  PubMed  Google Scholar 

  43. Lonnemann G, Sereni L, Lemke HD, Tetta C (2001) Pyrogen retention by highly permeable synthetic membranes during in vitro dialysis. Artif Organs 25:951–960.

    Article  CAS  PubMed  Google Scholar 

  44. Martín-Malo A, Carracedo J, Ramírez R, Rodriguez-Benot A, Soriano S, Rodriguez M, Aljama P (2000) Effect of uremia and dialysis modality on mononuclear cell apoptosis. J Am Soc Nephrol 11:936–942.

    PubMed  Google Scholar 

  45. Morgera S, Haase M, Rocktäschel J, Böhler T, von Heymann C, Vargas-Hein O, Krausch D, Zuckermann-Becker H, Müller JM, Kox WJ, Neumayer HH (2003) High permeability haemofiltration improves peripheral blood mononuclear cell proliferation in septic patients with acute renal failure. Nephrol Dial Transplant 18:2570–2576.

    Article  PubMed  Google Scholar 

  46. Morgera S, Haase M, Kuss T, Vargas-Hein O, Zuckermann-Becker H, Melzer C, Krieg H, Wegner B, Bellomo R, Neumayer HH (2006) Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure. Crit Care Med 34:2099–2104.

    Article  CAS  PubMed  Google Scholar 

  47. Morimoto H, Nakao K, Fukuoka K, Sarai A, Yano A, Kihara T, Fukuda S, Wada J, Makino H (2005) Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients. Nephrol Dial Transplant 20:2775–2782.

    Article  CAS  PubMed  Google Scholar 

  48. Munger MA, Ateshkadi A, Cheung AK, Flaharty KK, Stoddard GJ, Marshall EH (2000) Cardiopulmonary events during hemodialysis: effects of dialysis membranes and dialysate buffers. Am J Kidney Dis 36:130–139.

    Article  CAS  PubMed  Google Scholar 

  49. Poh CK, Hardy PA, Liao Z, Huang Z, Clark WR, Gao D (2003) Effect of spacer yarns on the dialysate flow distribution of hemodialyzers: a magnetic resonance imaging study. ASAIO J 49:440–448.

    PubMed  Google Scholar 

  50. Ponikvar JB, Rus RR, Kenda RB, Bren AF, Ponikvar RR (2001) Low-flux versus high-flux synthetic dialysis membrane in acute renal failure: prospective randomized study. Artif Organs 25:946–950.

    Article  CAS  PubMed  Google Scholar 

  51. Port FK, Wolfe RA, Hulbert-Shearon TE, Daugirdas JT, Agodoa LY, Jones C, Orzol SM, Held PJ (2001) Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: Results from the USRDS Dialysis Morbidity and Mortality Study. Am J Kidney Dis 37:276–286.

    Article  CAS  PubMed  Google Scholar 

  52. Ramírez R, Carracedo J, Soriano S, Jiménez R, Martín-Malo A, Rodríguez M, Blasco M, Aljama P (2005) Stress-induced premature senescence in mononuclear cells from patients on long-term hemodialysis. Am J Kidney Dis 45:353–359.

    Article  PubMed  Google Scholar 

  53. Randoux C, Gillery P, Georges N, Lavaud S, Chanard J (2001) Filtration of native and glycated beta2-microglobulin by charged and neutral dialysis membranes. Kidney Int 60:1571–1577.

    Article  CAS  PubMed  Google Scholar 

  54. Ronco C, Bowry S (2001) Nanoscale modulation of the pore dimensions, size distribution and structure of a new polysulfone-based high-flux dialysis membrane. Int J Artif Organs 24:726–735.

    CAS  PubMed  Google Scholar 

  55. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G (2000) Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356:26–30.

    Article  CAS  PubMed  Google Scholar 

  56. Ronco C, Brendolan A, Lupi A, Metry G, Levin NW (2000) Effects of a reduced inner diameter of hollow fibers in hemodialyzers. Kidney Int 58:809–817.

    Article  CAS  PubMed  Google Scholar 

  57. Ronco C, Bowry SK, Brendolan A, Crepaldi C, Soffiati G, Fortunato A, Bordoni V, Granziero A, Torsello G, La Greca G (2002) Hemodialyzer: from macro-design to membrane nanostructure; the case of the FX-class of hemodialyzers. Kidney Int Suppl. 80:126–142.

    Article  PubMed  Google Scholar 

  58. Ronco C, Bonello M, Bordoni V, Ricci Z, D’Intini V, Bellomo R, Levin NW (2004) Extracorporeal therapies in non-renal disease: treatment of sepsis and the peak concentration hypothesis. Blood Purif 22:164–174.

    Article  PubMed  Google Scholar 

  59. Ronco C, Levin N, Brendolan A, Nalesso F, Cruz D, Ocampo C, Kuang D, Bonello M, De Cal M, Corradi V, Ricci Z (2006) Flow distribution analysis by helical scanning in polysulfone hemodialyzers: effects of fiber structure and design on flow patterns and solute clearances. Hemodial Int 10:380–388.

    Article  PubMed  Google Scholar 

  60. Rosenkranz AR, Templ E, Traindl O, Heinzl H, Zlabinger GJ (1994) Reactive oxygen product formation by human neutrophils as an early marker for biocompatibility of dialysis membranes. Clin Exp Immunol 98:300–330.

    Article  CAS  PubMed  Google Scholar 

  61. Rousseau Y, Carreno MP, Poignet JL, Kazatchkine MD, Haeffner-Cavaillon N (1999) Dissociation between complement activation, integrin expression and neutropenia during hemodialysis. Biomaterials 20:1959–1967.

    Article  CAS  PubMed  Google Scholar 

  62. Sasaki M, Hosoya N, Saruhashi M (1999) Development of vitamin E-modified membrane. Contrib Nephrol 127: 49–70.

    Article  CAS  PubMed  Google Scholar 

  63. Satoh M, Yamasaki Y, Nagake Y, Kasahara J, Hashimoto M, Nakanishi N, Makino H (2001) Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters. Kidney Int 59:1943–195.

    Article  CAS  PubMed  Google Scholar 

  64. Schiffl H, Lang SM, Konig A, Strasser T, Haider MC, Held E (1994) Biocompatible membranes in acute renal failure: prospective case-controlled study. Lancet 344:570–572.

    Article  CAS  PubMed  Google Scholar 

  65. Schiffl H, Lang SM, Stratakis D, Fischer R (2001) Effects of ultrapure dialysis fluid on nutritional status and inflammatory parameters. Nephrol Dial Transplant 16:1863–1869.

    Article  CAS  PubMed  Google Scholar 

  66. Schindler R, Lonnemann G, Schäffer J, Shaldon S, Koch KM, Krautzig S (1994) The effect of ultrafiltered dialysate on the cellular content of interleukin-1 receptor antagonist in patients on chronic hemodialysis. Nephron 68:229–233.

    Article  CAS  PubMed  Google Scholar 

  67. Schindler R, Christ-Kohlrausch F, Frei U, Shaldon S (2003) Differences in the permeability of high-flux dialyzer membranes for bacterial pyrogens.Clin Nephrol 59:447–454.

    CAS  PubMed  Google Scholar 

  68. Simmons EM, Himmelfarb J, Sezer MT, Chertow GM, Mehta RL, Paganini EP, Soroko S, Freedman S, Becker K, Spratt D, Shyr Y, Ikizler TA; PICARD Study Group (2004) Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int 65:1357–1365.

    Article  CAS  PubMed  Google Scholar 

  69. Sirolli V, Ballone E, Di Stante S, Amoroso L, Bonomini M (2002) Cell activation and cellular-cellular interactions during hemodialysis: effect of dialyzer membrane. Int J Artif Organs 25:529–537.

    CAS  PubMed  Google Scholar 

  70. Sirolli V, Amoroso L, Pietropaolo M, Grandaliano G, Pertosa G, Bonomini M (2006) Platelet-leukocyte interactions in hemodialysis patients: culprit or bystander? Int J Immunopathol Pharmacol 19:461–470.

    CAS  PubMed  Google Scholar 

  71. Sitter T, Bergner A, Schiffl H (2000) Dialysate related cytokine induction and response to recombinant human erythropoietin in haemodialysis patients. Nephrol Dial Transplant 15:1207–1211.

    Article  CAS  PubMed  Google Scholar 

  72. Soriano S, Martín-Malo A, Carracedo J, Ramírez R, Rodríguez M, Aljama P (2005) Lymphocyte apoptosis: role of uremia and permeability of dialysis membrane. Nephron Clin Pract 100:c71–c77.

    Article  PubMed  Google Scholar 

  73. Sosa MA, Balk EM, Lau J, Liangos O, Balakrishnan VS, Madias NE, Pereira BJG, Jaber BL (2006) A systematic review of the effect of the Excebrane dialyser on biomarkers of lipid peroxidation. Nephrol Dial Transplant 21:2825–2833.

    Article  CAS  PubMed  Google Scholar 

  74. Stewart RD, Cerny JC, Mahon HI (1964) The capillary “kidney”: Preliminary report. Med Bull (Ann Arbor) 30:116–118.

    CAS  Google Scholar 

  75. Tarng DC, Huang TP, Liu TY, Chen HW, Sung YJ, Wei YH (2000) Effect of vitamin E-bonded membrane on the 8-hydroxy 2’-deoxyguanosine level in leukocyte DNA of hemodialysis patients. Kidney Int 58:790–799.

    Article  CAS  PubMed  Google Scholar 

  76. Thijs A, Grooteman MP, Zweegman S, Nubé MJ, Huijgens PC, Stehouwer CD (2007) Platelet activation during haemodialysis: comparison of cuprammonium rayon and polysulfone membranes. Blood Purif 25:389–394.

    Article  CAS  PubMed  Google Scholar 

  77. Tielemans C, Madhoun P, Lenaers M, Schandene L, Goldman M, Vanherweghem JL (1990) Anaphylactoid reactions during hemodialysis on AN69 membranes in patients receiving ACE inhibitors. Kidney Int 38:982–984.

    Article  CAS  PubMed  Google Scholar 

  78. Tielemans C, Husson C, Schurmans T, Gastaldello K, Madhoun P, Delville JP, Marchant A, Goldman M, Vanherweghem JL (1996) Effects of ultrapure and non-sterile dialysate on the inflammatory response during in vitro hemodialysis. Kidney Int 49:236–243.

    Article  CAS  PubMed  Google Scholar 

  79. Tumlin J, Wali R, Williams W, Murray P, Tolwani AJ, Vinnikova AK, Szerlip HM, Ye J, Paganini EP, Dworkin L, Finkel KW, Kraus MA, Humes HD (2008) Efficacy and safety of renal tubule cell therapy for acute renal failure. J Am Soc Nephrol 2008 Feb 13 [Epub ahead of print]

    Google Scholar 

  80. van Teijlingen ME, Nubé MJ, ter Wee PM, van Wijhe MH, Borgdorff P, Tangelder GJ (2003) Haemodialysis-induced pulmonary granulocyte sequestration in rabbits is organ specific. Nephrol Dial Transplant 18:2589–2595.

    Article  PubMed  Google Scholar 

  81. Verresen L, Waer M, Vanrenterghem Y, Michielsen P (1990) Angiotensin-converting-enzyme inhibitors and anaphylactoid reactions to high-flux membrane dialysis. Lancet 336:1360–1362.

    Article  CAS  PubMed  Google Scholar 

  82. Vos KD, Burris FO, Riley RL (1966) Kinetic study of the hydrolysis of cellulose acetate in the pH range of 2–10. J Appl Polymer Sci 10:825–832.

    Article  CAS  Google Scholar 

  83. Wanner C, Bahner U, Mattern R, Lang D, Passlick-Deetjen J (2004) Effect of dialysis flux and membrane material on dyslipidaemia and inflammation in haemodialysis patients. Nephrol Dial Transplant 19:2570–2575.

    Article  CAS  PubMed  Google Scholar 

  84. Ward RA, McLeish KR (1995) Hemodialysis with cellulose membranes primes the neutrophil oxidative burst. Artif Organs 9:801–807.

    Article  Google Scholar 

  85. Ward RA, Schaefer RM, Falkenhagen D, Joshua MS, Heidland A, Klinkmann H, Gurland HJ (1993) Biocompatibility of a new high-permeability modified cellulose membrane for haemodialysis. Nephrol Dial Transplant 8:47–53.

    CAS  PubMed  Google Scholar 

  86. Weber V, Linsberger I, Rossmanith E, Weber C, Falkenhagen D (2004) Pyrogen transfer across high- and low-flux hemodialysis membranes. Artif Organs 28:210–217.

    Article  CAS  PubMed  Google Scholar 

  87. Woods HF, Nandakumar M (2000) Improved outcome for haemodialysis patients treated with high-flux membranes. Nephrol Dial Transplant 15 (Suppl 1):S36–S42.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Detlef H. Krieter .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Krieter, D.H., Wanner, C. (2010). Membranes for Dialysis and Hemofiltration. In: Jörres, A., Ronco, C., Kellum, J. (eds) Management of Acute Kidney Problems. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69441-0_49

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-69441-0_49

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-69413-7

  • Online ISBN: 978-3-540-69441-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics